Daily evaluation and review of clinical stability (Days 3-5, typically)
Key point: Is patient getting better?
Assess: Do we need to continue antibiotics in a rapidly improving patient? If not improving, should therapy be changed?
React: Stopping anti-MRSA drugs when nasal PCR is negative or if cultures are negative for MRSA at 48 hours